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Acinetobacter baumannii is an emerging nosocomial pathogen prevalent in hospitals
worldwide. In order to understand the molecular epidemiology of multi-drug resistant
(MDR) A. baumannii, we investigated the genotypes of A. baumannii isolated from 10
hospitals in Shandong, China, from August 2013 to December 2013, by pulsed field gel
electrophoresis (PFGE) and multilocus sequence typing (MLST). Antimicrobial resistance
genes were analyzed by PCR and DNA sequencing. By PFGE analysis, we discovered 11
PFGE types in these 10 hospitals. By MLST, we assigned these isolates to 12 sequence
types (STs), 10 of which belong to the cloning complex CC92, including the prevalent
ST369, ST208, ST195, and ST368. Two new STs, namely ST794 and ST809, were
detected only in one hospital. All isolates of the MDR A. baumannii were resistant to
carbapenem, except 2 isolates, which did not express the blaOXA-23 carbapenemase
gene, indicating blaOXA-23 is the major player for carbapenem resistance. We also
discovered armA is likely to be responsible for amikacin resistance, and may play a
role in gentamicin and tobramycin resistance. aac(3)-I is another gene responsible for
gentamicin and tobramycin resistance. In summary, we discovered that the majority of
the isolates in Shandong, China, were the STs belonging to the CC92. Besides, two new
STs were detected in one hospital. These new STs should be further investigated for
prevention of outbreaks caused by A. baumannii.
Keywords: hospitals, multi-drug resistant Acinetobacter baumannii, molecular epidemiology, pulsed-field gel
electrophoresis, multilocus sequence typing
INTRODUCTION
Acinetobater baumannii has become one of the most important pathogens of nosocomial infection
in China (Wang F. et al., 2013; Hu et al., 2014, 2015). The emergence of multi-drug resistant (MDR)
A. baumannii strains has brought great difficulties to clinical treatment (Peleg et al., 2008; Doi et al.,
2009; Munoz-Price et al., 2013). According to a report from the China Antimicrobial Resistance
Surveillance System in 2013, A. baumannii is the most prevalent bacteria among all gram negative
bacilli and 56.0% of A. baumannii are resistant to carbapenem (Wang F. et al., 2013). In 2014, the
rate of resistance increased to 62% (Hu et al., 2015).
Jiang et al. Epidemiology of MDRABs in Shandong
Epidemiological studies of A. baumannii have been
constructed in Shandong, China (Ying C. et al., 2015), but
a province-wide survey has not been performed. Shandong, as
one of the richest regions in China, has an efficient and well-
developed transportation. Patients in Shandong often visit cities
other than their home city to seek an alternative therapy. This
raises the concern that hospital-to-hospital transfer of patients
may speed the spreading of MDR A. baumannii. In October
2013, after one patient infected with MDR A. baumannii was
transferred from a secondary hospital to the emergency ward
of Hospital-1, Tai’an, Shandong, China, MDR A. baumannii
with high homology was constantly detected in the sputum
specimens of patients hospitalized in the intensive care unit
(ICU) (unpublished data).
The aim of this study was to characterize the epidemiology
of the MDR A. baumannii, prevalent in Shandong, China. Ten
public tertiary-care teaching hospitals (Figure 1) well-spreading
in Shandong, China and equipped with advanced medical
facilities were selected for this study. The genotypes of the
strains of A. baumannii isolated from patients were analyzed by
pulsed field gel electrophoresis (PFGE) and multilocus sequence
typing (MLST) to determine the clonal relatedness, and the
genetic characteristics responsible for carbapenem and other
antimicrobial resistance mechanisms were identified.
MATERIALS AND METHODS
Ethics Statement
Samples were collected during a routine checkup by medical
professionals. The study was carried out in accordance with
the approved guidelines of the Ethics Committee of Tai’an City
FIGURE 1 | Geographical locations of the 10 tertiary-care teaching hospitals in Shandong, China.
Central Hospital with written informed consent from all subjects.
All subjects gave written informed consent in accordance with the
Declaration of Helsinki.
Hospital Setting and Data Collection
This study was performed at 10 public tertiary-care teaching
hospitals (termed hospital-1 to -10) located in the major cities
with a large population in Shandong Province, China from
August 2013 to December 2013 (Figure 1). All of these hospitals
equipped with more than 20 beds within the long-stay intensive
care unit (ICU) and 1000 beds in other wards, serving more than
10,000 admissions per year. A total of 154 isolates were identified
from different clinical specimens of patients administered in
either ICU or other wards during this period, including sputum,
urine, wound, or cerebrospinal fluid (Table 1).
Bacterial Identification and Antimicrobial
Susceptibility Test
Bacterial species were identified by using an VITEK-2
bacterial instrument (BioMerieux, Lyons, France) following
the manufacturer’s instruction. Antimicrobial susceptibility
testing was performed by three different methods: the sensitivity
of meropenem and cefotaxime was determined by the disk
diffusion method; the sensitivity of tigecycline and polymyxin
B was determined by the Etest method (AB Biodisk, Solna,
Sweden); the sensitivity of other antimicrobial agents was
detected using the VITEK-GN13 drug susceptibility card. The
criteria of the susceptibility of the GN13 card, meropenem,
and cefotaxime were adapted from the Clinical and Laboratory
Standards Institute (CLSI; http://clsi.org/standards/). The
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TABLE 1 | The source of the A. baumannii strains and the ward distribution in the 10 tertiary-care teaching hospitals.
Hospital No. Sample sourcesa Isolation wardsb
SP UR WO AP CF ICU NSW RW NW HSW CW TSW GW BW ED
1 001–026 26 16 2 1 1 1 5
2 027–041 12 1 1 1 11 1 2 1
3 042–056 15 14 1
4 057–071 15 15
5 072–084 13 13
6 085–099 11 3 1 6 5 1 2 1
7 100–109 4 4 2 3 2 1 2 2
8 110–119 8 2 7 3
9 120–145 26 14 5 4 1 2
10 146–154 9 3 3 1 2
Sum 154 139 2 8 1 4 102 21 6 5 4 1 1 5 4 5
aSP, sputum; UR, urine; WO, wound; AP, abdominal paracentesis; CF, Cerebrospinal fluid.
b ICU, intensive care unit; NSW, Neurosurgery ward; RW, Respiratory ward; NW, Neurology ward; HSW, Hand surgery ward; CW, Cardiology ward; TSW, Thoracic surgery ward; GW,
Geriatrics ward; BW, Burn ward; ED, Emergency Department.
criteria of the susceptibility of tigecycline were adapted from the
United States Food and Drug Administration (http://www.fda.
org.uk/sitemap.aspx).
Pulsed Field Gel Electrophoresis
PFGE was performed as described elsewhere (Ribot et al., 2006).
In brief, the chromosomal DNA of A. baumannii was digested
with 60 U of ApaI (Takara, Dalian, China) in a 37◦C water
bath. With a Salmonella serotype Braenderup strain (H9812)
digested with XbaI (Takara, Dalian, China) as the molecular
weight standard, the DNA fragments were separated on a 0.8%
agarose gel in 0.5 × TBE using a clamped homogeneous electric
field electrophoresis-Mapper XA system (Bio-Rad, California,
USA). The experimental conditions were set up as follows: the
initial and final switch time of 5 and 20 s, respectively, an included
angle of 120◦ and a gradient of 6 V/cm for 20 h at 14◦C. The
PFGE images were handled using the Gel Doc software (Bio-
Rad, California, USA) according to the operation manual. The
PFGE results of 154 strains were disposed using the BioNumerics
software (Applied Maths, Belgium) with the uniform marker
normalization to record the strip position. A threshold of 85%
homology was set to define clonal clustering of PFGE types.
Multilocus Sequence Typing
MLST was performed using the method previously described
(Bartual et al., 2005). An internal portion of seven housekeeping
genes was amplified by PCR, including citrate synthase (gltA),
DNA gyrase subunit B (gyrB), glucose dehydrogenase B (gdhB),
homologous recombination factor (recA), 60-kDa chaperonin
(cpn60), glucose-6-phosphate isomerase (gpi), RNA polymerase
σ70 factor (rpoD), and phospho-glucomutase (pgm). PCR
experiments were carried out according to a previously described
method (Bartual et al., 2005). DNA sequences were analyzed
using the MLST database for A. baumannii (http://pubmlst.
org/abaumannii) and accordingly the sequence types (STs) were
assigned.
Detection of Drug Resistance Genes
DNAs were extracted and amplified by PCR. The primers
were designed as previously described (Zhi et al., 2005; Shen
et al., 2008; Yang et al., 2011) for the related resistance genes of
carbapenemases, including blaIMP, blaKPC, blaNDM-1, blaOXA-23,
blaOXA-24, blaOXA-48, blaOXA-50, blaOXA-51, blaOXA-55,
blaOXA-58, blaOXA-60, and blaOXA64, for the 16s methylase,
including armA and rmtB, and for the aminoglycoside resistance
genes, including aac(3)-I, aac(3)-II, aac(3)-III, aac(3)-IV, aac(6′)-
I, aac(6′)-II, aph(3′)-VI, ant(3′′)-I, and ant(2′)-I. The primers for
blaNDM−1 were designed based on the gene sequence announced
by the China Disease Prevention and Control Center (Jia et al.,
2014).
Sequence Analysis
The positive products of PCRwere sequenced by Shanghai Sunny
Biotechnology Co., Ltd. (Shanghai, China), and the sequences
were compared to the Genbank database.
RESULTS
From August 20, 2013 to December 20, 2013, we identified
154 strains of A. baumannii, isolated from clinical cases in 10
public tertiary-care teaching hospitals in Shandong Province,
China (Table 1).A. baumanniiwas initially isolated from sputum
(139), urine (2), wound (8), abdominal paracentesis (1), and
cerebrospinal fluid (4). Hospital-1 and Hospital-9 were the places
where most isolates were identified, with 26 strains in each. More
than 66.2% of the isolates (102) were isolated from ICU. In
Hospital-4 and -5, ICU was the only place where A. baumannii
was found.
PFGE
The A. baumannii isolates were assigned to different PFGE types
(Figure 2). The isolates in some hospitals, such as Hospital-
1, -6, and -9, only had one PFGE type, while in other
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FIGURE 2 | ApaI PFGE profiles of representative A. baumannii Isolates. (A–J): isolates from Hospital-1 to -10, respectively. The 85% was set as a cutoff to
define PFGE types. The dendrogram was generated by the BioNumerics software.
hospitals, such as Hospital-5, the isolates had as many as five
PFGE Types. The PFGE types were further classified to clonal
types when the genetic similarity is higher than 85%. The
isolates from Hospital-1, -6, and -9 represented one clonal
type (Figures 2A,F,I); hospital-8 and -10 had two clonal types
(Figures 2H,J); three clonal types were found in hospital-2, -4,
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TABLE 2 | The distribution of STs of MDRAB in each hospital.
Hospital MLST
ST 369 ST 208 ST 195 ST 191 ST 368 ST 540 ST 218 ST 469 ST 451 ST 809 ST 794 ST 381
Hospital-1 13 6 1 2 4 – – – – – – –
Hospital-2 – 6 – 8 1 – – – – – – –
Hospital-3 – 1 4 – 6 – 3 – – – – 1
Hospital-4 – 5 5 2 – – – 3 – – – –
Hospital-5 1 1 6 – – – – – 2 2 1 –
Hospital-6 5 6 4 – – – – – – – – –
Hospital-7 1 3 1 2 3 – – – – – – –
Hospital-8 – – – 1 – 9 – – – – – –
Hospital-9 26 – – – – – – – – – – –
Hospital-10 – – 6 1 – – 1 – 1 – – –
Sum 46 28 27 16 14 9 4 3 3 2 1 1
“–,” no ST was detected in this hospital.
and -7 (Figures 2B,D,G); and hospital-3 and -5 had four and five
clonal types, respectively (Figures 2C,E).
MLST
A total of 12 STs were designated for the isolates by the
MLST analysis, including ST369 (29.9%), ST208 (18.2%), ST195
(17.5%), ST191 (10.4%), ST368 (9.1%), ST540 (5.8%), ST218
(2.6%), ST469 (1.9%), ST451 (1.9%), ST809 (1.3%), ST794
(0.65%), and ST381 (0.65%; Table 2). ST369 is the most
representing ST, however, it mainly appeared in two hospitals,
Hospital-1 (13) and Hospital-9 (26). ST208 and ST195 were the
widest distributed STs, both of which appeared in seven of these
10 hospitals. None of the STs has been found in all hospitals.
On the contrary, some STs only appeared in one particular
hospital. For example, nine ST368 and one ST381 were found
only in Hospital-8 and Hospital-3, respectively. Among these
12 STs, 10 STs (except ST809 and ST794) have been reported
belonging to the prevalent cloning complex CC92 (Runnegar
et al., 2010). The other two STs, namely ST794 and ST809, were
identified as new STs, only appeared in Hospital-5. They are
singleton, and do not belong to any clone complex. To make
a cross-hospital comparison of the isolates, representatives of
different STs obtained from each hospital were selected to plot
the dendogram (Figure 3). Using the genetic similarity >85% as
a cutoff, 38 isolates can be classified into 11 PFGE types.
Antimicrobial Susceptibility Testing
The antimicrobial susceptibility profiles of 154 A. baumannii
strains isolated from August 20, 2013 to December 20, 2013
are shown in Table 3, most of which showed a multiple-
antimicrobial-resistant phenotype. All strains were resistant
to piperacillin/tazobactam, cefepime, ceftazidime, cefotaxime,
ceftriaxone, and piperacillin. A total of 152 out of 154 isolates
were resistant to the carbapenems tested, namely imipenem and
meropenem. One hundred and thirty eight strains were resistant
to levofloxacin and ciprofloxacin. None of the 154 strains were
resistant to polymyxin B, and only 10 isolates were resistant
to tigecycline. Other relatively effective antibiotics include
TABLE 3 | Antimicrobial susceptibility profiles of A. baumannii isolates.
Antibiotic Resistant Intermediate Susceptible
Number Rate Number Rate Number Rate
(%) (%) (%)
imipenem 152 98.7 0 0.0 2 1.3
meropenem 152 98.1 0 0.0 2 1.3
piperacillin/
tazobactam
154 100 0 0.0 0 0.0
cefepime 154 100 0 0.0 0 0.0
ceftazidime 154 100 0 0.0 0 0.0
cefotaxime 154 100 0 0.0 0 0.0
ceftriaxone 154 100 0 0.0 0 0.0
levofloxacin 138 89.6 13 8.4 3 1.9
ciprofloxacin 138 89.6 13 8.4 3 1.9
amikacin 143 92.9 0 0.0 11 7.1
tobramycin 145 94.2 0 0.0 9 5.8
gentamicin 145 94.2 0 0.0 9 5.8
piperacillin 154 100 0 0.0 0 0.0
tigecycline 10 6.5 21 13.6 123 79.9
Trimethoprim/
sulfamethoxazole
142 92.2 0 0.0 12 7.8
polymyxin B 0 0.0 0 0.0 154 100
amikacin, and trimethoprim/sulfamethoxazole, which showed
antimicrobial activity against 11 and 12 isolates, respectively.
Carbapenemase Genes
The genes of blaIMP, blaKPC, blaNDM-1, blaOXA-24, blaOXA-48,
blaOXA-50, blaOXA-55, blaOXA-58, and blaOXA-60 were not
detected in this study. As shown in Table 4, the blaOXA-51-like
genes were detected in all 154 MDR A. baumannii isolates, and
the blaOXA-23 gene was found in 152 isolates. The isolates had
different blaOXA-51-like genes; 87 strains had the blaOXA-66 gene
and the other 67 strains had the blaOXA-197 gene (Table 4).
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FIGURE 3 | Dendogram of A. baumannii strains selected from 10 hospitals. At least one representative of all different STs obtained from each hospital was
selected to make the dendogram. The 85% was set as a cutoff to define PFGE types. The dendrogram was generated by the BioNumerics software.
Detection of the 16s Methylation Enzymes
and Aminoglycoside Resistance Genes
As shown in Table 4, 143 strains had the 16s methylation
enzyme armA and the number of strains encoding other
aminoglycoside resistance genes, namely aac(6′)-I, ant(3′′)-I,
aac(3)-I, and aac(3)-IV, were 91,119,45 and 1, respectively.
The genes of rmtB and aac(3)-II, aac(3)-III, and ant(2′′)-
I were not detected. The presence of armA is particularly
important for amikacin resistance. All 11 strains without
armA were susceptible to amikacin (Table 4). Out of these 11
strains, two strains containing both aac(3)-I and ant(3′′)-I were
gentamicin and tobramycin resistant. However, the strain only
containing the ant(3′′)-I gene was not resistant to aminoglycoside
antimicrobial.
DISCUSSION
In this study, we investigated the genetic diversity of the A.
baumannii isolates from 10 tertiary-care teaching hospitals in
Shandong, China. All of these hospitals are located in an
urban area serving more than 1 million residents and equipped
with advanced medical facilities, making them a great fit for
the purpose of this study. Our results show that 104 of 154
A. baumannii were isolated from patients in ICU, which is
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TABLE 4 | Distribution of the carbapenemase genes, aminoglycoside genes, carbapenem resistance, and aminoglycoside antimicrobial resistance of the
isolates.
Strains
No.
blaOXA-23 Carbapenemase
gene
Carbapenem
resistance
Antimicrobial resistant
genes of aminoglycoside
Aminoglycoside
antimicrobial resistance
spectrum
blaOXA-51
a Imipenem Meropenem armA aac(6′)-I ant(3′′)-I aac(3)-I aac(3)-IV amikacin gentamicin tobramycin
blaOXA-66 blaOXA-197
25 + + − R R + − − − − R R R
3 + + − R R − − + − − S S S
39 + + − R R + + + − − R R R
2 + + − R R + − + − − R R R
3 + + − R R + − + + − R R R
9 + + − R R + + + + − R R R
2 + + − R R − − − − − S S S
1 + + − R R − − + + − S R R
1 + + − R R + + + − + R R R
1 − + − S S + − + + − R R R
1 − + − S S + + + + − R R R
4 + − + R R − − − − − S S S
13 + − + R R + + + + − R R R
1 + − + R R − − + + − S R R
4 + − + R R + − − − − R R R
28 + − + R R + + + − − R R R
16 + − + R R + − + + − R R R
1 + − + R R + − + − − R R R
Sum 152 87 67 143 91 119 45 1
“+” indicates the gene was detected; “−” indicates the gene was not detected; “R” indicates the strain was resistant to the antibiotic; “S” indicates the strain was susceptible to antibiotic.
ablaOXA-66 and blaOXA-197 are allelic variants of intrinsic blaOXA-51.
consistent with previous reports (Jiang et al., 2013, 2014). It
has been reported that mechanical ventilation of ICU is a
risk factor for cross infection of A. baumannii (Raka et al.,
2009; Chaulagain et al., 2012). MDR A. baumannii may cause
severe respiratory infection symptoms, aggravating the medical
conditions of patients in ICU.
The isolates were assigned to 11 PFGE types determined
by PFGE (Wang X. et al., 2013). In hospitals like Hospital-
6 and Hospital-9, only one PFGE type was found for 15 and
26 isolates, respectively. Using the genetic similarity >85%
as a cutoff, we were able to classify the PFGE types into
clonal groups to further illustrate the relatedness of these
isolates. For example, the isolates in Hospital-1 have a genetic
similarity >85% and they were classified into the same clonal
group.
MLST is another discriminatory typing method for A.
baumannii. By MLST, we were able to assign the isolates to
12 STs, which were correlated with the clonal distribution by
PFGE (Adams-Haduch et al., 2011). Among the 12 STs, 10 STs
belong to the CC92, ST794, and ST809 were identified as new
STs, which only appeared in Hospital-5. The main MLST types
of A. baumannii were ST92 and ST75 in many countries in Asia
and the Pacific region, such as Australia, China, India, Japan, and
South Korea (Kamolvit et al., 2015). A collection of 398 strains of
A. baumanniiwere isolated from seven regions in southern China
over the period from January 2012 to June 2012. ST208 was the
major type among them, followed by ST191 and ST729 (Ying J.
et al., 2015). Overall, the predominant STs of MDR A. baumannii
might be different in different hospitals, areas, and countries. In
our study, we identified ST208 and ST191, which are single-locus
variants of ST92. However, we did not observe any ST92, ST75,
and ST729.
We discovered ST369 was transmitted by a patient transferred
from a secondary hospital to Hospital-1, supporting the notion
of the inter-hospital transmission of A. baumannii (unpublished
data). The common STs prevalent in these hospitals, including
ST369, ST208, ST195, ST191, and ST368, may also be a result of
inter-hospital transmission (Figure 3). Among these STs, three,
namely ST369, ST368, ST195, have been isolated in the Southwest
Hospital of Chongqing, China (Huang et al., 2014). Hospital
infection control department should not only pay attention to
the spreads of drug resistant bacteria in hospital, but also should
focus on the spreads of drug resistant strains among hospitals.
Among the STs identified, ST794 and ST809 were new STs
only identified in Hospital-5. Hospital-5 is located in Qingdao,
one of the hottest tourist destinations in China. These isolates
may be evolved from local strains, but we cannot rule out the
possibility of transmission from tourists. Such transmission has
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previously demonstrated by the case of blaNDM-1, which spread
from India to Swedish by a tourist (Macfadden et al., 2015). Close
attentions should be paid toward these new STs to avoid further
transmission between hospitals.
The carbapenemase encoding genes were investigated to
decipher the mechanism of carbapenem resistance. Our results
show that lacking of the blaOXA-23 gene led to both imipenem and
meropenem susceptible of the isolates, indicating the blaOXA-23
gene plays an important role in regulating carbapenem resistance.
A. baumannii carrying the blaOXA-23 gene distributes widely in
many regions in China (Ruan et al., 2013). It has also shown
the blaOXA-23 gene was one of the most common genes in
many other countries, such as Saudi Arabia, the United Arab
emirates, Oman, Qatar, Bahrain, and Kuwait (Zowawi et al.,
2015). The carbapenem resistance of A. baumannii, is related to
the production of the OXA-23 type carbapenemases (Runnegar
et al., 2010; Mosqueda et al., 2013). In the isolates where
the blaOXA-23 gene was absent, the blaOXA-66, gene, an allelic
variant of intrinsic blaOXA-51, was expressed; the isolates were
carbapenem susceptible. Interestingly, one study has shown that
A. baumannii isolates only containing the blaOXA-66 gene were
susceptible to carbapenem, but when blaOXA-66 gene is converted
to blaOXA-82, the A. baumannii isolates become carbapenem
resistant (Zander et al., 2013). Other blaOXA genes, such as
blaOXA-40, can be also involved in the process of carbapenem
resistance (Héritier et al., 2003).
Genes responsible for aminoglycoside resistance were also
investigated. Multiply genes were involved in the regulation of
the resistance pathway for aminoglycosides. One gene, armA
was particularly important for amikacin resistance. Without the
presence of armA, the strains were amikacin susceptible. armA
may play an important role in gentamicin and tobramycin
resistance too, as shown in the 29 strains which only expressed
the armA gene. However, other genes may also be involved in
gentamicin and tobramycin resistance, such as aac(3)-I. In five
strains, where armA was not expressed, when only the ant(3′′)-I
gene was expressed, the isolates were gentamicin and tobramycin
susceptible; when both ant(3′′)-I and aac(3)-I were expressed,
the isolates were gentamicin and tobramycin resistant, indicating
aac(3)-I is responsible for gentamicin and tobramycin resistance
in these strains without armA. Our results are in consistent with
previous studies, which showed the armA gene is responsible
for the resistance to aminoglycoside antibiotic (Yokoyama et al.,
2003; Liu et al., 2012). The roles of the other two genes, namely
aac(6′)-I and aac(3)-IV are not clear, since we did not obtain
strains with the presence of these two genes alone. Out of the
154 isolates, 10 were resistant to tigecycline. Tigecycline, as well
as Polymyxin B, is still one of the most effective therapeutic
options in our study, which is consistent with previous studies
(Zavascki et al., 2007; Karageorgopoulos et al., 2008; Kassamali
et al., 2015). Further investigation should be carried out to
decipher the underlying mechanism of the antibiotic resistance
of A. baumannii.
In summary, we investigated the molecular epidemiology of
the MDR A. baumannii isolated from 10 public tertiary hospitals
in Shandong, China. Our results provide an in-depth analysis of
the genetic variability of the A. baumannii strains in this region.
PFGE and MLST are two commonly used typing methods, by
which, we were able to understand not only the evolution of
the strains within one given hospital, but also the hospital-to-
hospital transmission. Our results show that blaOXA-23 is the
major player for carbapenem resistance. In addition, armA is
likely to be responsible for amikacin resistance, and may play
a role in gentamicin and tobramycin resistance, and aac(3)-
I is another gene responsible for gentamicin and tobramycin
resistance. By the epidemiological study, we hope to pave the road
for the establishment of an effective drug resistance monitoring
system, and prevention of further spread and outbreaks of the
MDR A. baumannii.
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